Login
$NCNO
$23.42 +$0.25 (1.08%) Close

Consolidated balance sheets

In millions of USD, except per-share amounts
Q2 FY2027
As of Jul 31, 2026
Q1 FY2027
As of Apr 30, 2026
Q4 FY2026
As of Jan 31, 2026
Q3 FY2026
As of Oct 31, 2025
Q2 FY2026
As of Jul 31, 2025
Q1 FY2026
As of Apr 30, 2025
Q4 FY2025
As of Jan 31, 2025
Q3 FY2025
As of Oct 31, 2024
Q2 FY2025
As of Jul 31, 2024
Q1 FY2025
As of Apr 30, 2024
Q4 FY2024
As of Jan 31, 2024
Q3 FY2024
As of Oct 31, 2023
Q2 FY2024
As of Jul 31, 2023
Q1 FY2024
As of Apr 30, 2023
Q4 FY2023
As of Jan 31, 2023
Q3 FY2023
As of Oct 31, 2022
Q2 FY2023
As of Jul 31, 2022
Q1 FY2023
As of Apr 30, 2022
Q4 FY2022
As of Jan 31, 2022
Assets
Current assets
Cash and cash equivalents (VIE: $3,421 and $6,232 at January 31, 2026 and July 31, 2026, respectively)
Accounts receivable, less allowances of $2,825 and $1,922 at January 31, 2026 and July 31, 2026, respectively
Costs capitalized to obtain revenue contracts, current portion, net
Prepaid expenses and other current assets
Total current assets
Property and equipment, net
Operating lease right-of-use assets, net
Costs capitalized to obtain revenue contracts, noncurrent, net
Goodwill
Intangible assets, net
Investments
Long-term prepaid expenses and other assets
Total assets
Liabilities, redeemable non-controlling interest, and stockholders’ equity
Current liabilities
Accounts payable
Accrued compensation and benefits
Accrued expenses and other current liabilities
Deferred revenue, current portion
Debt, current portion, net
Financing obligations, current portion
Operating lease liabilities, current portion
Total current liabilities
Operating lease liabilities, noncurrent
Deferred income taxes, noncurrent
Deferred revenue, noncurrent
Revolving credit facility, noncurrent
Debt, noncurrent, net
Financing obligations, noncurrent
Other long-term liabilities
Total liabilities
Redeemable non-controlling interest (Note 2)
Stockholders’ equity
Preferred stock, $0.001 par value; 10,000,000 shares authorized, and none issued and outstanding at January 31, 2026 and July 31, 2026
Common stock, $0.0005 par value; 500,000,000 shares authorized at January 31, 2026 and July 31, 2026; 118,868,921 and 120,921,732 shares issued; 113,904,867 and 105,129,104 outstanding at January 31, 2026 and July 31, 2026, respectively
Treasury stock, at cost; 4,964,054 and 15,792,628 shares at January 31, 2026 and July 31, 2026, respectively
Additional paid-in capital
Accumulated other comprehensive income
Accumulated deficit
Total stockholders’ equity
Total liabilities, redeemable non-controlling interest, and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support